Value through Innovation27 July 2016

Clinical Study Results

  • BI 34021 - Healthy
    Clinical Study Number 1258.1
    Study Indication Healthy
    Product BI 34021
    Generic Name BI 34021
    Lab Code
    Clinical Phase I
    Study Title

    Safety, tolerability and pharmacokinetics of BI 34021 FU2 oral drinking solution in healthy male volunteers (dose range: 5 - 500 mg). A double-blind (within dose groups), randomised, placebo-controlled within dose groups,single-rising dose study, including re-dosing at 50 mg and 150 mg (food effect) and at 100 mg (two 50 mg tablets)

    Study Document Trial synopsis 1258.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.